Carcinoid SyndromeSymptoms, Doctors, Treatments, Advances & More
Carcinoid Syndrome Overview
Learn About Carcinoid Syndrome
Carcinoid syndrome is a group of symptoms associated with a complication from neuroendocrine tumors (NETs), which used to be called carcinoid tumors. These are tumors most often of the small intestine, colon, appendix, pancreas, or bronchial tubes in the lungs.
Flush syndrome; Functioning argentaffinoma syndrome; Neuroendocrine tumors; NETs
Carcinoid syndrome is the pattern of symptoms sometimes seen in people with NETs. These tumors are rare, and often slow-growing. Most NETs are found in the gastrointestinal tract and lungs.
Carcinoid syndrome only occurs in a few people with NET, typically after the tumor has spread to the liver.
These tumors release too much of the hormone serotonin, as well as several other chemicals. These hormones cause the blood vessels to open (dilate). This causes carcinoid syndrome.
Carcinoid syndrome consists of four main symptoms:
- Flushing (face, neck, or upper chest), or widened blood vessels seen on the skin (telangiectasias)
- Difficulty breathing, such as wheezing
- Diarrhea
- Heart problems, such as leaking heart valves, blood pressure changes, and heart palpitations
Symptoms may be triggered by physical exertion or consumption of certain foods and beverages such as blue cheese, chocolate, and red wine.
Surgery to remove the tumor is usually the first treatment. It can permanently cure the condition if the tumor is completely removed.
If the tumor has spread to the liver, treatment involves either of the following:
- Removing areas of the liver that have tumor cells
- Sending (infusing) medicine directly into the liver to destroy the tumors
When the entire tumor can't be removed, removing large portions of the tumor ("debulking") can help relieve the symptoms.
For people with advanced NETs that can't be removed with surgery, octreotide (Sandostatin) or lanreotide (Somatuline) injections are given to shrink or slow the growth of the tumor.
Some common medicines, like selective serotonin reuptake inhibitors (SSRIs), such as paroxetine (Paxil) and fluoxetine, may make symptoms worse by increasing levels of serotonin. However, do not stop taking these medicines unless your provider tells you to do so.
Boston University Radiation Oncology Inc.
Matthew Kulke is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Kulke is rated as an Elite provider by MediFind in the treatment of Carcinoid Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Dr. Kulke is currently accepting new patients.
Winship Cancer Institute Of Emory University
Daniel Halperin is a primary care provider, practicing in Family Medicine in Atlanta, Georgia. Dr. Halperin is rated as an Elite provider by MediFind in the treatment of Carcinoid Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, and Metastatic Insulinoma. Dr. Halperin is board certified in American Board Of Internal Medicine - Medical Oncology, 2015.
MN - Cancer
Thorvardur Halfdanarson is a Hematologist and an Oncologist practicing medicine in Rochester, Minnesota. Dr. Halfdanarson is rated as an Elite provider by MediFind in the treatment of Carcinoid Syndrome. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Hepatectomy. Dr. Halfdanarson is currently accepting new patients.
Learn more about carcinoid syndrome and get support from:
- Neuroendocrine Cancer Foundation -- www.ncf.net/supportline
- Neuroendocrine Tumor Research Foundation -- netrf.org/for-patients/
The outlook for people with carcinoid syndrome is different from the outlook for people who have a NET without the syndrome. Most people with a NET will not develop carcinoid syndrome.
In people with carcinoid syndrome, the tumor has usually spread to the liver. This lowers the survival rate. Overall, the prognosis is usually poor.
Complications of carcinoid syndrome may include:
- Increased risk of falls and injury (from low blood pressure)
- Bowel obstruction (from the tumor)
- Gastrointestinal bleeding
- Heart valve failure
A fatal form of carcinoid syndrome, carcinoid crisis, may occur as a side effect of surgery, anesthesia or chemotherapy.
Contact your provider for an appointment if you have symptoms of carcinoid syndrome.
Treating the tumor reduces the risk of carcinoid syndrome.
Published Date: August 06, 2026
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
De Herder WW, Feelders RA, Hofland J. Neuroendocrine tumors and disorders. In: Melmed S, Auchus RJ, Goldfine AB, Rosen CJ, Kopp PA, eds. Williams Textbook of Endocrinology. 15th ed. Philadelphia, PA: Elsevier; 2025:chap 43.
Gan T, Evers BM. Small intestine. In: Townsend Jr CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. 21st ed. St. Louis, MO: Elsevier; 2022:chap 50.
National Cancer Institute website. Gastrointestinal neuroendocrine tumors treatment (PDQ) - health professional version. www.cancer.gov/types/gi-neuroendocrine-tumors/hp/gi-neuroendocrine-treatment-pdq. Updated September 19, 2024. Accessed February 24, 2025.
Wolin EM, Jensen RT. Neuroendocrine neoplasms. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 213.
